Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
15/04/2026
McGrath: Upgrade JD.com's rating from neutral to outperform the market.
Latest
2 m ago
Samsung Electronics' sixth-generation high-bandwidth memory (HBM4) yield is still below 60%. The company plans to increase the yield of HBM4 DRAM to near completion level in the second half of this year to speed up response times for major artificial intelligence customers, including NVIDIA. On the other hand, Samsung Electronics' 1c DRAM yield has exceeded 80%, reaching the so-called "mature yield." (ChosunBiz)
2 m ago
Samsung Electronics' HBM4 yield rate is still below 60%.
3 m ago
Compute power chip stocks fluctuate and rise, with Muxi Technologies rising more than 10%, Cambricon Technologies rising over 6%, and Anru Technology, Moore Thread, Chengdu Huawei, and Higlight Information following suit.
3 m ago
State Council Taiwan Affairs Office: The obstacle to the full resumption of cross-strait direct flights lies entirely with the DPP authorities.
5 m ago
State Administration for Market Regulation: cracking down on monopoly practices in the pharmaceutical industry will always be a top priority to maintain a high pressure situation.
See all latest